Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ivanyi

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
World Journal of Urology|January 25, 2011
Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patientsC Seidel, M Fenner, A S Merseburger, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1990
HLA class-I-transgenic mice as model system to study MHC-restricted antigen recognition in manE H Weiss, G Schliesser, C Botteron, et al.
Human Immunology|November 1, 1986
Blind confirmation in Leiden of Geczy factor on the cells of Dutch patients with ankylosing spondylitisA F Geczy, A van Leeuwen, J J van Rood, et al.
World Journal of Urology|November 21, 2015
Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?P Ivanyi, J Koenig, A Trummer, et al.
Journal of Immunogenetics|April 1, 1986
Anti-MHC immunity detected prior to intentional alloimmunization. IV. Natural monoclonal H-2-specific antibodiesR Cerny-Provaznik, T Kloosterman, D Verkerk, et al.
Transplantation Proceedings|December 21, 2010
Self-expanding metallic stent placement with laryngeal mask in lung transplant recipientsT Fuehner, O Wiesner, C DeWall, et al.
Clinical & Experimental Metastasis|March 24, 2021
Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?P Ivanyi, T Park-Simon, H Christiansen, et al.
Immunogenetics|October 31, 2001
The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complexT M Tran, P Ivanyi, I Hilgert, et al.
European Journal of Immunology|January 1, 1987
Induction of H-2-specific antibodies by injections of syngeneic Sendai virus-coated cellsF Kievits, A Rocca, A Opolski, et al.
Human Immunology|February 13, 2001
Strong association of HLA-B27 heavy chain with beta 2-microglobulinT M Tran, V Horejsí, S Weinreich, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
World Journal of Urology|January 25, 2011
Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patientsC Seidel, M Fenner, A S Merseburger, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1990
HLA class-I-transgenic mice as model system to study MHC-restricted antigen recognition in manE H Weiss, G Schliesser, C Botteron, et al.
Human Immunology|November 1, 1986
Blind confirmation in Leiden of Geczy factor on the cells of Dutch patients with ankylosing spondylitisA F Geczy, A van Leeuwen, J J van Rood, et al.
World Journal of Urology|November 21, 2015
Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?P Ivanyi, J Koenig, A Trummer, et al.
Journal of Immunogenetics|April 1, 1986
Anti-MHC immunity detected prior to intentional alloimmunization. IV. Natural monoclonal H-2-specific antibodiesR Cerny-Provaznik, T Kloosterman, D Verkerk, et al.
Transplantation Proceedings|December 21, 2010
Self-expanding metallic stent placement with laryngeal mask in lung transplant recipientsT Fuehner, O Wiesner, C DeWall, et al.
Clinical & Experimental Metastasis|March 24, 2021
Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?P Ivanyi, T Park-Simon, H Christiansen, et al.
Immunogenetics|October 31, 2001
The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complexT M Tran, P Ivanyi, I Hilgert, et al.
European Journal of Immunology|January 1, 1987
Induction of H-2-specific antibodies by injections of syngeneic Sendai virus-coated cellsF Kievits, A Rocca, A Opolski, et al.
Human Immunology|February 13, 2001
Strong association of HLA-B27 heavy chain with beta 2-microglobulinT M Tran, V Horejsí, S Weinreich, et al.
Pageof 9